Shangara S. Dehal

Statistics

Publications

Citations

1.8K

H-Index

Active since

1980

Affiliations

University of Massachusetts Chan Medical School(Current)

BD Biosciences (United States)

Foundation for Biomedical Research

Washington State University

Research Triangle Park Foundation

Shangara S. Dehal is an author at University of Massachusetts Chan Medical School specializing in pharmacology, cytochrome p450 enzymes, and cytochrome p450-mediated metabolism.

Publications per year

1980–2016

Publications

IN VITRO INHIBITION OF UDP GLUCURONOSYLTRANSFERASES BY ATAZANAVIR AND OTHER HIV PROTEASE INHIBITORS AND THE RELATIONSHIP OF THIS PROPERTY TO IN VIVO BILIRUBIN GLUCURONIDATION

Donglu Zhang, Theodore J. Chando, Donald W. Everett et al. · Drug Metabolism and Disposition · 2005 · 286 citations

Life Sciences, Biochemistry, Pharmacology +17

Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies.

Kevin W. Gaido, Susan C. Maness, D P McDonnell et al. · PubMed · 2000 · 225 citations

Life Sciences, Endocrinology, Pharmacology +17

Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies

Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell et al. · Molecular Pharmacology · 2000 · 196 citations

Life Sciences, Endocrinology, Pharmacology +17

CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver.

Shangara S. Dehal, David Kupfer · PubMed · 1997 · 188 citations

Medicine, Biochemistry, Pharmacology +17

HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE

David M. Stresser, Marc I. Broudy, Thuy Ho et al. · Drug Metabolism and Disposition · 2004 · 128 citations

Medicine, Medicinal Chemistry, Pharmacology +15

1–5 of 25